Treatment of sepsis

The Lancet Infectious Diseases

Volumn 12, Issue 10, 2012, Pages 745-746

  van Saeene, Hendrick K ^a   Silvestri, Luciano ^b   Taylor, Nia ^a   Petros, Andy ^c   Bion, Julian ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Unit of Anaesthesia and Intensive Care   (Italy)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; ENDOTOXIN; POLYMYXIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BLOODSTREAM INFECTION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE; LETTER; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEPSIS;

HUMANS; PROTEIN C; SEPSIS;

EID: 84866629875     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70230-X     Document Type: Letter

References (6)

1. For sepsis, the drugs don't work. Lancet Infect Dis 2012, 12:89. The Lancet Infectious Diseases.
2. Bion J, Taylor N, Petros AJ, Silvestri L, van Saene HKF Selective digestive decontamination and antibiotic resistance. Lancet Infect Dis 2012, 12:181.
3. Silvestri L, van Saene HKF, de la Cal MA, et al. Surviving sepsis campaign needed consensus to exclude selective decontamination of the digestive tract. Crit Care Med 2008, 36:2716-2717.
4. de Smet AM, Kluytmans JA, Blok HE, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011, 11:372-380.
5. Petros AJ, Taylor N, van Saene HKF, Silvestri L Gut overgrowth harms the critically ill. Intensive Care Med 2011, 37:1560-1562.
6. Conraads VM, Jorens PG, De Clerk LS, et al. Selective intestinal decontamination in advanced chronic heart failure: a pilot trial. Eur J Heart Fail 2004, 6:483-491.